High sensitive  have been helping emergency room doctors in Europe determine whether a patient experiencing symptoms is having a heart attack. Now ��«����Ƶ's test is helping doctors take care to the next level by focusing on prevention.

��«����Ƶ's test is so sensitive that it can also detect low levels of troponin-I that indicate if a person is at increased risk of a future heart attack or cardiac event, potentially months to years before symptoms occur.

A substantial amount of research has shown that measuring a person's troponin levels using ��«����Ƶ's high sensitive troponin-I test provides better predictive information for determining a person's chances of developing a future cardiovascular disease when added to the current standard of care.^2-6

To currently predict a person's chances of developing heart disease, European guidelines recommend that physicians use several indirect health factors: for example, cholesterol levels, blood pressure, as well as if they have diabetes or are a smoker. ��«����Ƶ's test uses a biomarker that is a direct signal from the heart.

"This life-changing technology can help physicians have a clearer picture of their patient's likelihood of having a cardiac event in the future”, said Gillian Murtagh, M.D., a cardiologist and Associate Medical Director at ��«����Ƶ. "Having access to this additional information helps ensure the correct medical treatment is given to high risk patients and can help prevent unnecessary testing and costs for low risk patients."